BioGend Therapeutics Co., Ltd. (TPEX:6733)
31.70
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST
BioGend Therapeutics Revenue
In the year 2024, BioGend Therapeutics had annual revenue of 167.65M TWD with 52.53% growth. BioGend Therapeutics had revenue of 50.58M in the quarter ending December 31, 2024, with 27.81% growth.
Revenue
167.65M
Revenue Growth
+52.53%
P/S Ratio
23.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.94B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |